BiotechTube
Home/Novonesis/Andrew Fordyce
AF

Andrew Fordyce

EVP, Health & Biosciences

Novonesis

Therapeutic Areas

Gut HealthImmune SupportMetabolic Health

Novonesis Pipeline

DrugIndicationPhase
Next-Gen Food EnzymesFood Processing Efficiency & SustainabilityLate-stage Development
Advanced Probiotic BlendsGut-Brain Axis / Immune SupportEarly Development
Microbial Agricultural SolutionsBiocontrol & Plant HealthMid-stage Development
Enzymes for BiorefiningAdvanced Biofuel ProductionPilot Scale
Animal Gut Health ModulatorsAntibiotic Reduction in LivestockCommercial Development
Enzymes for Plastic DegradationPolyester (PET) DegradationEarly Research

Leadership Team at Novonesis

EB
Ester Baiget
President & Chief Executive Officer
LG
Lars Green
Chief Financial Officer
CC
Claus Crone Fuglsang
Chief Scientific Officer
KM
Kasper Munk Nielsen
Chief Operating Officer
View full Novonesis profile